Crucell will use J&J investment to boost R&D funding

02/9/2010 | Reuters

Crucell plans to use its partnership with Johnson & Johnson to increase its research funding and speed up development of its pipeline treatments. The Dutch biotech firm, which is seeking a new growth engine, spent about $96 million on R&D last year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN